Could a single daily pill deliver Parkinson’s medication?

News

Author: Simge Eva DoganPublished: 1 October 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

NTU Assoc Prof Joachim Loo and LiberaTx COO Shashi Kesavapany holding their new drug microcapules in their hands

Scientists at Nanyang Technological University, Singapore, have developed a new pill that could be used to slowly deliver medication over a 24-hour period to people living with Parkinson’s disease.

They hope that delivering Parkinson’s medication in this way could help manage symptoms which can occur when people experience ‘off’ periods between taking medications. A team at the university’s startup LiberaTx is now commercialising the technology and planning clinical trials to test the efficacy of the pill.

Joachim Loo (pictured left), associate professor at the university and founder of LiberaTx, said: “We hope that […] reducing dosage to just once-a-day would greatly improve patient compliance, lower the pill burden of these patients, while alleviating the ‘off’ periods that these patients experience. Achieving this would greatly improve quality of life for the patient.”

If the pill is proven successful for treating Parkinson’s disease, it may also be used for treating other conditions that require taking multiple drugs daily.

Lead image credit: NTU Singapore


Read more:

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Go Back

Share this story

Comments


Related articles


Global update

6 of the world’s biggest Parkinson’s fundraising walks

Get walking for Parkinson’s in events around the world

READ MORE
Rosemary maguire

Perspectives

Leading campaigners pay tribute to pioneering Parkinson’s nurse

Praising the “huge contribution” of late Parkinson’s specialist nurse

READ MORE
10-Breakthroughs

Advances

10 breakthrough Parkinson’s therapies to watch out for

Coffee to marijuana, the broader breakthrough picture is exciting

READ MORE